Figure 1. Sacubitril–valsartan vs ACEI/ARB for the primary composite outcomes among men and women for systolic and diastolic dysfunction.

A, Readmission for heart failure or death; B, readmission for heart failure, death, stroke, MI, or cardiac arrest. ACEI indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; and MI, myocardial infarction.